Commercial_Aquaculture_Vaccines_.jpg

Commercial Aquaculture Vaccines Market Size, Share & Trends Analysis Report By Pathogen Types (Bacteria and Viruses), Fish Species (Salmon, Tilapia, Bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpur), End-Users, Region, And Segment Forecasts, 2023-2031

Report Id: 1027 Pages: 190 Published: 27 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Commercial Aquaculture Vaccines Market Size is valued at 470.8 Million in 2024 and is predicted to reach 968.1 Million by the year 2034 at a 7.3 % CAGR during the forecast period for 2025-2034.

Commercial Aquaculture Vaccines Market info

Key Industry Insights & Findings from the Report:

  • The increasing consumption of seafood and the rising need for efficient disease management in intensive aquaculture systems boost the demand for vaccines
  • Innovations in vaccine technology, including species-specific formulations and advanced delivery methods, are enhancing the effectiveness of disease prevention in aquaculture.
  • Europe region dominated the overall market and accounted for a global revenue share in 2023.
  • Economic factors, such as fluctuations in fish prices and the financial instability of fish farming operations, can affect the ability of farmers to invest in vaccines.

Aquaculture is known as the farming of aquatic animals such as fish, tilapia, shrimp, molluscs, and Sea Bass in water. Aquaculture is the better source of income for the food industry. Vaccination plays an important role in commercial Aquaculture. Vaccination would be the best option to reduce bacterial and viral infections in aquaculture. The demand of the aquaculture vaccines market has been rising due to the advancements in the field of fish farming. Modern and advanced technologies, development, and launch of new aquaculture vaccines for different species enhance the growth of the aquaculture vaccines market.

The rising prevalence of bacterial infections among aquatic species is expected to boost demand for the commercial aquaculture vaccines market over the forecast period. Additionally, increasing global consumption and production of aquatic species has heightened the aquaculture vaccines market opportunities. However, the COVID-19 pandemic has created a negative impact on the aquaculture vaccines market. Also, rising awareness of animal-to-human pathogen transmission risks is expected to pull down the market for a short period of time. Moreover, stringent regulatory policies for approval of aquaculture vaccines, complex manufacturing procedures of vaccines, and the high cost of vaccines will limit the growth of the aquaculture vaccines market.

Competitive Landscape

Some of The Key Players in The Commercial Aquaculture Vaccines Market:

  • IDT Biologika GmbH (Ridgeway Biologicals Ltd)
  • MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.)
  • Ceva Biovac
  • Zoetis (PHARMAQAS)
  • Vaxxinova
  • Barramundi Asia Pte Ltd. (UVAXX Asia)
  • HIPRA
  • AniCon Labor GmbH
  • sanphar (ipeve)
  • Kennebec River Biosciences
  • Merck & Co. Inc.
  • Tecnovax
  • HIPRA
  • Virbac
  • Veterquimica S.A.
  • FeedVAX
  • KoVax (Phibro Animal Health)
  • Nisseiken Co., Ltd.
  • Other Prominent Players

Market Segmentation

The commercial aquaculture vaccines market is segmented into Pathogen Types, Fish Species, End-users and Regions. The Pathogen Types segment is further bifurcated into Bacteria and Viruses. In terms of Fish Species, the market can be divided into Salmon, Tilapia, Bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpur. By End-users, the market is segmented into Fish Farming companies and Aquatic research institute. Based on the region, the commercial aquaculture vaccines market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Main regions of this market are North America, Europe, and Asia-Pacific. Asia-Pacific market is expected to grow faster in the future due to the growing aquaculture industry and development in vaccination. China is the leading country of this region.

Bacteria segment will drive the growth of the aquaculture vaccines market during the forecast period due to the rising prevalence of bacterial infections among aquatic species. Based on the fish species segment, salmon is a widely dominating species in the market, due to growing demand and rising production of salmon in leading developed countries and this will boost the aquaculture vaccines market in the future. Among the different end-users, fish farming companies will create more opportunities in this market.

Recent Developments:

  • In February 05, 2024 Merck Animal Health, Merck & Co., Inc., Rahway, N.J., USA (MSD Animal Health outside the U.S. and Canada), announced that it will purchase Elanco Animal Health Incorporated aqua business for $1.3 billion in cash. An unique portfolio of aquatic species medications, vaccines, nutritionals, and supplements, two aqua manufacturing sites in Canada and Vietnam, and a Chilean research center were acquired. The transaction is expected to close by mid-2024, pending regulatory approvals and other closing procedures.

The Commercial Aquaculture Vaccines Market Report Scope

Report Attribute

Specifications

Market Size Value In 2024

USD 470.8 Million

Revenue Forecast In 2034

USD 968.1 Million

Growth Rate CAGR

CAGR of 7.6% from 2025 to 2034

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2025 to 2034

Historic Year

2021 to 2024

Forecast Year

2025-2034

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Pathogen Types, By Fish Species, By End-Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia

Competitive Landscape

IDT Biologika GmbH (Ridgeway Biologicals Ltd), MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.), Ceva Biovac, Zoetis (PHARMAQAS), Vaxxinova, Barramundi Asia Pte Ltd. (UVAXX Asia), HIPRA, AniCon Labor GmbH, Sanphar (ipeve), Kennebec River Biosciences, and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

 

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Global Commercial Aquaculture Vaccines Market Segmentation

Global Commercial Aquaculture Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Pathogen Types

  • Bacteria
  • Virus

Commercial Aquaculture Vaccines Market

Global Commercial Aquaculture Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Fish Species

  • Salmon
  • Tilapia
  • Bream
  • Labris Bergylta
  • Cyprinus Carpio
  • Sea Bass
  • Trout
  • Cyclopterus Lumpus

Global Commercial Aquaculture Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on End-Users

  • Fish Farming companies
  • Aquatic research institute

Global Commercial Aquaculture Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Commercial Aquaculture Vaccines Market revenue (US$ Million) by Country, 2019 to 2030

  • U.S.
  • Canada

Europe Commercial Aquaculture Vaccines Market Revenue (US$ Million) by Country, 2019 to 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Commercial Aquaculture Vaccines Market Revenue (US$ Million) by Country, 2019 to 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Commercial Aquaculture Vaccines Market Revenue (US$ Million) by Country, 2019 to 2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Commercial Aquaculture Vaccines Market Revenue (US$ Million) by Country, 2019 to 2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Email field cannot be blank!(Use email format)
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1220
Security Code field cannot be blank!
Frequently Asked Questions

Mobile Healthcare Clinic Market Size is valued at USD 2.11 Bn in 2024 and is predicted to reach USD 5.82 Bn by the year 2034

The Mobile Healthcare Clinic Market is expected to grow at a 10.8% CAGR during the forecast period for 2025-2034.

ADI Mobile Health, The Armor Group, Inc., Odulair, LLC, Matthew Speciality Vehicles, Farber Specialty Vehicles, MinFound Medical Systems Co., Ltd, Pit

Mobile Healthcare Clinic Market is segmented on the basis of service type, vehicle type, and design layout.

North America region is leading the Mobile Healthcare Clinic Market.